Eisenmann, E.D.; Garrison, D.A.; Talebi, Z.; Jin, Y.; Silvaroli, J.A.; Kim, J.-G.; Sparreboom, A.; Savona, M.R.; Mims, A.S.; Baker, S.D.
Interaction of Antifungal Drugs with CYP3A- and OATP1B-Mediated Venetoclax Elimination. Pharmaceutics 2022, 14, 694.
https://doi.org/10.3390/pharmaceutics14040694
AMA Style
Eisenmann ED, Garrison DA, Talebi Z, Jin Y, Silvaroli JA, Kim J-G, Sparreboom A, Savona MR, Mims AS, Baker SD.
Interaction of Antifungal Drugs with CYP3A- and OATP1B-Mediated Venetoclax Elimination. Pharmaceutics. 2022; 14(4):694.
https://doi.org/10.3390/pharmaceutics14040694
Chicago/Turabian Style
Eisenmann, Eric D., Dominique A. Garrison, Zahra Talebi, Yan Jin, Josie A. Silvaroli, Jin-Gyu Kim, Alex Sparreboom, Michael R. Savona, Alice S. Mims, and Sharyn D. Baker.
2022. "Interaction of Antifungal Drugs with CYP3A- and OATP1B-Mediated Venetoclax Elimination" Pharmaceutics 14, no. 4: 694.
https://doi.org/10.3390/pharmaceutics14040694
APA Style
Eisenmann, E. D., Garrison, D. A., Talebi, Z., Jin, Y., Silvaroli, J. A., Kim, J.-G., Sparreboom, A., Savona, M. R., Mims, A. S., & Baker, S. D.
(2022). Interaction of Antifungal Drugs with CYP3A- and OATP1B-Mediated Venetoclax Elimination. Pharmaceutics, 14(4), 694.
https://doi.org/10.3390/pharmaceutics14040694